Knowledge and awareness of biosimilars among oncology patients in Colorado, USA.
Future Oncol
; 15(22): 2577-2584, 2019 Aug.
Article
en En
| MEDLINE
| ID: mdl-31339051
ABSTRACT
Aim:
We aimed to improve oncology patients' knowledge and awareness of biosimilars. Subsequently, we conducted an assessment of this knowledge by use of an anonymous online survey. Patients &methods:
Printed materials discussing major topics related to biosimilars were developed during Phase I of our educational initiative. The brochures contained a link to the online survey.Results:
A total of 79 patients responded to our survey. More than 70% of survey participants selected the correct definition of biosimilars and nearly 80% did so on questions focused on regulation, adverse reactions reporting and cost issues related to biosimilars.Conclusion:
Our results indicate a good level of both knowledge and awareness of major topics concerning biosimilars among our survey participants.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Conocimientos, Actitudes y Práctica en Salud
/
Biosimilares Farmacéuticos
/
Oncología Médica
/
Neoplasias
Tipo de estudio:
Qualitative_research
Límite:
Female
/
Humans
/
Male
País como asunto:
America do norte
Idioma:
En
Año:
2019
Tipo del documento:
Article